Researchers found that patients with both bronchiectasis and chronic rhinosinusitis are more likely to test positive for Pseudomonas aeruginosa (P aeruginosa).
Researchers found that patients with both bronchiectasis and chronic rhinosinusitis are more likely to test positive for Pseudomonas aeruginosa (P aeruginosa).
Read More
The PMX 900 features a 0.4-micron filter designed to block airborne contaminants and protect equipment in healthcare environments.
Read More
Chemicals released by gut microbes and captured from the breath can reveal the composition of the bacteria living in the intestines.
Read More
Tuberculosis (TB) precision medicine may shorten therapy by using clinical phenotypes to guide stratified treatment with monitoring.
Read More
Aboard the International Space Station, bacteria-infecting viruses and their hosts accumulate distinctive mutations in near-weightlessness.
Read More
Pseudomonas aeruginosa (P. aeruginosa) bloodstream infection carried recurrence and mortality, with illness driving risk in Queensland adult cohort.
Read More
Higher rates of Legionnaires’ disease were found in ZIP codes served by water treatment plants that use chlorine as the primary disinfectant.
Read More
A new compound that kills tuberculosis bacteria by inhibiting ATP synthase at a different site than existing drugs like bedaquiline.
Read More
A pneumococcal enzyme, zmpB, is a key factor in some pneumonia patients develop serious heart complications.
Read More
Staphylococcus aureus (S. aureus) delays wound healing through a mechanism that suppresses skin cell metabolism needed for repair.
Read More
Whooping cough is on the rise and incidence now exceeds pre-pandemic numbers.
Read More
UCLA Health detected and halted a rare strain of Pseudomonas aeruginosa that carries a gene called NDM-1, or New Delhi metallo-β-lactamase.
Read More
Researchers have identified more than 200 phage defense strategies used by bacteria to avoid viral infection.
Read More
Researchers using green light to activate penicillin say controlling drug activity with light will allow precise and safe treatment of localized infections.
Read More
Some patients with pre-extensively drug-resistant TB benefitted from shorter, simpler regimens.
Read More
Cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant infections compared to all other non-cancer patients.
Read More
Community-acquired pneumonia is one of the most common infections in children worldwide and represents one of the most frequent and costliest reasons US children are hospitalized.
Read More
Nasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Read More
Scientists are developing sensor-based tests to quickly detect superbugs like K. pneumoniae, S. aureus, and P. aeruginosa.
Read More
The ECRI’s annual list of patient safety threats includes healthcare-associated infections and medical misinformation, but it’s topped by a particular physician behavior towards patients and caregivers that can lead to a loss of trust.
Read More
Funding from the Cystic Fibrosis Foundation will support development of a breath test to diagnose Pseudomonas aeruginosa infections in CF patients.
Read More
Viromed Medical AG is reporting positive results for its PulmoPlas therapy in the treatment of ventilator-associated pneumonia (VAP) in intensive care unit patients.
Read More
Funds from NIH will advance ALX1 as a potential treatment in cystic fibrosis and other chronic lung diseases.
Read More
Cystic fibrosis patients with elevated levels of bacteria infected by Pf phage in their sputum experience a faster decline in lung function.
Read More
